Australian IP Litigation Round-Up 31 May 2013
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal as of 31 May 2013.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal as of 31 May 2013.
An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 30 May 2013.
Schedule 2 of the INTELLECTUAL PROPERTY LAWS AMENDMENT BILL 2013 read before the House of Representatives on 30 May 2013 proposes amendments to enable least-developed and developing countries to source generic versions of patented pharmaceutical products from Australia to treat public health crises. In this, the second of 6 posts relating to the proposed changes, …
>> Read more
On 30 May 2013, the Australian Parliament was presented a Bill for an Act to amend legislation relating to intellectual property, called the Intellectual Property Laws Amendment Bill 2013 (report here). The first schedule of the bill proposes amendments which address Crown use provisions based on recommendations contained in the Productivity Commission’s 2013 Report on …
>> Read more
Today, the Australian Parliament was presented a Bill for an Act to amend legislation relating to intellectual property, called the Intellectual Property Laws Amendment Bill 2013. This is not to be confused with the Intellectual Property Laws Amendment Act 2012 (aka the Raising the Bar legislation) which came into effect on 15 April 2013.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal as of 24 May 2013. We advise our clients (whether as IP owners or as alleged infringers) and act for them in relation to patent litigation, trade mark litigation, registered design litigation, domain name, plant breeder’s rights, confidential information and copyright litigation. Contact us …
>> Read more
An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 23 May 2013. If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
With the recent media coverage of Angelina Jolie’s decision to have a preventative double mastectomy following genetic testing for BRCA mutations and with the price of this genetic test (approximately $3000AUD) from Myriad Genetics often being referred to, we were curious as to what is actually involved in the test.
A breif round-up of upcoming events in the Australian Sustainability/Clean Tech space.
An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 16 May 2013.